BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17639583)

  • 21. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
    Xu W; Fan H; He X; Zhang J; Xie W
    J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital mesoblastic nephroma and trisomy 11.
    Dal Cin P; Lipcsei G; Hermand G; Boniver J; Van den Berghe H
    Cancer Genet Cytogenet; 1998 May; 103(1):68-70. PubMed ID: 9595049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study.
    Vokuhl C; Nourkami-Tutdibi N; Furtwängler R; Gessler M; Graf N; Leuschner I
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
    Zhang FR; He XB; Yang YH; Xie W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
    Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
    Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivation of the maternally imprinted IGF2 allele in TGFalpha induced hepatocellular carcinomas in mice.
    Harris TM; Rogler LE; Rogler CE
    Oncogene; 1998 Jan; 16(2):203-9. PubMed ID: 9464538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-PCR.
    Yun K; Soejima H; Merrie AE; McCall JL; Reeve AE
    J Pathol; 1999 Apr; 187(5):518-22. PubMed ID: 10398115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
    Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T
    Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus.
    Waterland RA; Lin JR; Smith CA; Jirtle RL
    Hum Mol Genet; 2006 Mar; 15(5):705-16. PubMed ID: 16421170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
    Li Y; Meng G; Huang L; Guo QN
    Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6-NTRK3 fusion, and the rare KLHL7-BRAF fusion.
    Zhao M; Yin M; Kuick CH; Chen H; Aw SJ; Merchant K; Ng EHQ; Gunaratne S; Loh AHP; Gu W; Tang H; Chang KTE
    Histopathology; 2020 Oct; 77(4):611-621. PubMed ID: 32590884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of imprinting of IGF2 in Ewing's sarcoma.
    Zhan S; Shapiro DN; Helman LJ
    Oncogene; 1995 Dec; 11(12):2503-7. PubMed ID: 8545106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of CDKN1C in Beckwith Wiedemann syndrome.
    Algar E; Brickell S; Deeble G; Amor D; Smith P
    Hum Mutat; 2000; 15(6):497-508. PubMed ID: 10862080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
    Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
    J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Good prognosis of cellular mesoblastic nephroma with hyperdiploidy and relaxation of imprinting of the maternal IGF2 gene.
    Becroft DM; Mauger DC; Skeen JE; Ogawa O; Reeve AE
    Pediatr Pathol Lab Med; 1995; 15(5):679-88. PubMed ID: 8597855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
    Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
    Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.
    Yun K; Fukumoto M; Jinno Y
    Am J Pathol; 1996 Apr; 148(4):1081-7. PubMed ID: 8644850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement.
    El Demellawy D; Cundiff CA; Nasr A; Ozolek JA; Elawabdeh N; Caltharp SA; Masoudian P; Sullivan KJ; de Nanassy J; Shehata BM
    Pathology; 2016 Jan; 48(1):47-50. PubMed ID: 27020209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
    Li H; Zhang N
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.